Cambridge Investment Research Advisors, Inc. Bio Rad Laboratories, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$304.11 - $351.99 $1.26 Million - $1.46 Million	4,139 Added 628.07%	4,798 $1.66 Million
Q4 2023 Feb 09, 2024	SELL	$269.37 - $365.04 $8,889 - $12,046	-33 Reduced 4.77%	659 $213,000
Q3 2023 Oct 24, 2023	SELL	$350.25 - $422.63 $14,010 - $16,905	-40 Reduced 5.46%	692 $248,000
Q2 2023 Jul 13, 2023	SELL	$359.49 - $486.4 $60,034 - $81,228	-167 Reduced 18.58%	732 $278,000
Q1 2023 May 11, 2023	SELL	$418.69 - $503.0 $20,934 - $25,150	-50 Reduced 5.27%	899 $431,000
Q4 2022 Feb 08, 2023	BUY	$351.71 - $456.01 $49,591 - $64,297	141 Added 17.45%	949 $399,000
Q3 2022 Oct 17, 2022	SELL	$412.59 - $563.26 $57,762 - $78,856	-140 Reduced 14.77%	808 $337,000
Q2 2022 Jul 13, 2022	SELL	$463.67 - $597.16 $44,048 - $56,730	-95 Reduced 9.11%	948 $469,000
Q1 2022 May 12, 2022	SELL	$524.57 - $735.42 $135,863 - $190,473	-259 Reduced 19.89%	1,043 $587,000
Q4 2021 Feb 03, 2022	SELL	$708.84 - $794.68 $238,170 - $267,012	-336 Reduced 20.51%	1,302 $983,000
Q3 2021 Nov 02, 2021	BUY	$657.71 - $825.77 $132,199 - $165,979	201 Added 13.99%	1,638 $1.22 Million
Q2 2021 Aug 10, 2021	BUY	$576.64 - $649.04 $194,327 - $218,726	337 Added 30.64%	1,437 $925,000
Q1 2021 May 07, 2021	BUY	$547.01 - $662.35 $191,453 - $231,822	350 Added 46.67%	1,100 $628,000
Q4 2020 Feb 04, 2021	BUY	$510.68 - $643.45 $139,415 - $175,661	273 Added 57.23%	750 $437,000
Q3 2020 Oct 29, 2020	BUY	$454.43 - $535.6 $216,763 - $255,481	477 New	477 $245,000

Others Institutions Holding BIO

# of Institutions

455

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account